Liquet Medical
Glen Allen, US · Founded 2021 · Delaware corporation · 4 employees on LinkedIn · 1 known investors
Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.
Founders & leadership
Liquet Medical was founded in 2021 by John Schindler and Derek Hall.
JS
John SchindlerCEO, Co-Founder, Board Member
DH
Derek HallCOO, Co-Founder, Board Member
PH
Paul H. SartoriNamed on SEC filing
JJ
John J. SchindlerNamed on SEC filing
DR
Derek R. HallNamed on SEC filing
GC
Gary C. CupitNamed on SEC filing
KS
Koren SchindlerNamed on SEC filing
Board
GN
Gabriele NiederauerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$3.3M disclosed across 6 rounds · 2021–2026
▶$75KraisedMar 2026 · 2 investors · Other Health CareRule 506(b)
▶$75KraisedMar 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul SartoriDirector
- Derek HallExecutive Officer, Director
- Mary ByronDirector
- Gabriele NiederauerDirector
- John SchindlerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $75K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedMay 2025 · 15 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2025 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gabriele NiederauerDirector
- Derek R. HallExecutive Officer, Director, Promoter
- John J. SchindlerExecutive Officer, Director, Promoter
- Paul H. SartoriDirector, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $25K
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$615KraisedMay 2025 · 13 investors · BiotechnologyRule 506(b)
▶$615KraisedMay 2025 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul H. SartoriDirector, Promoter
- Gabriele NiederauerDirector
- John J. SchindlerExecutive Officer, Director, Promoter
- Derek R. HallExecutive Officer, Director, Promoter
- Offering amount
- $800K
- Amount sold
- $615K
- Minimum investment
- $10K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$405KraisedMay 2023 · 4 investors · BiotechnologyRule 506(b)
▶$405KraisedMay 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul H. SartoriExecutive Officer, Director, Promoter
- Derek R. HallExecutive Officer, Director, Promoter
- John J. SchindlerExecutive Officer, Director, Promoter
- Gary C. CupitDirector, Promoter
- Koren SchindlerExecutive Officer, Promoter
- Offering amount
- $1M
- Amount sold
- $405K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$605KraisedJun 2022 · 7 investors · BiotechnologyRule 506(b)
▶$605KraisedJun 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Derek HallExecutive Officer, Director, Promoter
- Koren SchindlerExecutive Officer, Promoter
- Paul SatoriExecutive Officer, Director, Promoter
- Gary CupitDirector, Promoter
- John SchindlerExecutive Officer, Director, Promoter
- Offering amount
- $1.4M
- Amount sold
- $605K
- Minimum investment
- $25K
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$550KraisedOct 2021 · 7 investors · BiotechnologyRule 506(b)
▶$550KraisedOct 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John SchindlerExecutive Officer, Director, Promoter
- Koren SchindlerExecutive Officer, Promoter
- Gary CupitDirector, Promoter
- Derek HallExecutive Officer, Director, Promoter
- Paul SartoriDirector, Promoter
- Offering amount
- $2M
- Amount sold
- $550K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapTactile Medical3 shared keywordsTactile Medical develops at-home pneumatic compression devices (including the Nimbl controller) to treat lymphedema and chronic venous insufficiency, and airway clearance therapy (AffloVest) for people with chronic respiratory and neuromuscular conditions. It also provides clinical education and patient support around these therapies, primarily serving patients in the United States.
Performance Health3 shared keywordsPerformance Health supplies rehabilitation and physical therapy products, including hot and cold packs, compression sleeves, and splinting technology such as Chrisofix, distributed directly to point of care. It serves clinicians, patients, and veterans across North America, including fulfillment of VA contracts.
Companies competing with Liquet Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Liquet Medical do?
- Liquet Medical develops localized drug delivery technology for treating vascular disease. The company focuses on medical devices aimed at improving patient outcomes in vascular care.
- Who founded Liquet Medical?
- Liquet Medical was founded by John Schindler, Derek Hall in 2021.
- Who are Liquet Medical's investors?
- Liquet Medical's investors include Lighthouse Network Ventures Llc.
- How much funding has Liquet Medical raised?
- Liquet Medical has disclosed $3.3M raised across 6 rounds.
- Where is Liquet Medical headquartered?
- Liquet Medical is headquartered in Glen Allen, US.